Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SIGMOID and Dr. Falk have entered into an exclusive license, development and option agreement to advance Sigmoid’s SmPill® cyclosporine franchise in EuropeDr. Falk has made an up-front equity...
-
DUBLIN, Ireland, March 06, 2017 (GLOBE NEWSWIRE) -- SIGMOID PHARMA LIMITED, a privately-owned pharmaceutical company developing innovative therapeutics for gastrointestinal and immunological...
-
DUBLIN, Ireland, March 01, 2016 (GLOBE NEWSWIRE) -- SIGMOID PHARMA LIMITED, a privately-owned, specialty pharmaceutical company developing innovative therapeutics for gastrointestinal and...
-
DUBLIN, Ireland, Feb. 04, 2016 (GLOBE NEWSWIRE) -- SIGMOID PHARMA LIMITED, a privately-owned, specialty pharmaceutical company developing innovative therapeutics for gastrointestinal and...